Dae Yong Kim

Summary

Affiliation: College of Medicine
Country: Korea

Publications

  1. ncbi Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Radiat Oncol 8:114. 2013
  2. ncbi Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 82:e193-9. 2012
  3. ncbi Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection
    Tae Hyun Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 77:1158-65. 2010
  4. ncbi Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 82:856-62. 2012
  5. ncbi Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers
    Seok Byung Lim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang si, Korea
    Ann Surg 248:243-51. 2008
  6. ncbi Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 78:164-71. 2010
  7. ncbi Comparative analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
    Strahlenther Onkol 181:601-5. 2005
  8. ncbi CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer
    Tae Hyun Kim
    Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 81:e743-8. 2011
  9. ncbi Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study
    Yong Sang Hong
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea
    Int J Radiat Oncol Biol Phys 79:1171-8. 2011
  10. ncbi Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Tumori 99:93-9. 2013

Collaborators

Detail Information

Publications71

  1. ncbi Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Radiat Oncol 8:114. 2013
    ..Also, patterns of failure, particularly distant metastasis (DM), were analyzed according to tumor location within the rectum...
  2. ncbi Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 82:e193-9. 2012
    ..To investigate the prognostic significance of tumor volume reduction rate (TVRR) after preoperative chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC)...
  3. ncbi Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection
    Tae Hyun Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 77:1158-65. 2010
    ....
  4. ncbi Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 82:856-62. 2012
    ..To investigate, in a comparative analysis, the prognostic implications of postchemoradiotherapy (post-CRT) pathologic stage (ypStage) vs. postoperative pathologic stage (pStage) in rectal cancer...
  5. ncbi Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers
    Seok Byung Lim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang si, Korea
    Ann Surg 248:243-51. 2008
    ..To evaluate the effect of the time interval between chemoradiotherapy (CRT) and surgery on CRT response and surgical outcomes...
  6. ncbi Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 78:164-71. 2010
    ....
  7. ncbi Comparative analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
    Strahlenther Onkol 181:601-5. 2005
    ..The combination of the belly board and bladder distension showed an additive effect and was the most effective method for reducing the irradiated small-bowel volume...
  8. ncbi CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer
    Tae Hyun Kim
    Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 81:e743-8. 2011
    ..In patients with pancreatic cancer treated with curative resection, we evaluated the effect of clinicopathologic parameters on early distant metastasis within 6 months (DM6m) to identify patients who might benefit from surgery...
  9. ncbi Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study
    Yong Sang Hong
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea
    Int J Radiat Oncol Biol Phys 79:1171-8. 2011
    ..We performed a prospective concurrent CRT Phase II study with irinotecan and capecitabine in patients with locally advanced rectal cancer to investigate the efficacy and safety of this regimen...
  10. ncbi Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Tumori 99:93-9. 2013
    ..We aimed to investigate the significance of CEA as a prognostic or predictive factor in rectal cancer patients receiving preoperative chemoradiotherapy (CRT)...
  11. ncbi Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer
    Dae Yong Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 67:378-84. 2007
    ..To describe our experience with a bolus injection of 5-fluorouracil and leucovorin (FL) vs. capecitabine in terms of radiologic and pathologic findings in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer...
  12. ncbi KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials
    Sun Young Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 85:201-7. 2013
    ....
  13. ncbi Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan ro, Ilsandong gu, Goyang si, Gyeonggi do 410 769, Republic of Korea
    Jpn J Clin Oncol 40:754-60. 2010
    ..To investigate the long-term outcomes of selected patients with cT3 distal rectal cancer treated with local excision following pre-operative chemoradiotherapy...
  14. ncbi Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study
    Sun Young Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 81:677-83. 2011
    ..To evaluate the efficacy and safety of preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with rectal cancer...
  15. ncbi Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma
    Dongho Shin
    Proton Therapy Center, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    Int J Radiat Oncol Biol Phys 72:687-94. 2008
    ..To evaluate the influence of lipiodol on the proton beam range, which has not yet been determined...
  16. ncbi Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer
    Tae Hyun Kim
    Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 81:e853-9. 2011
    ..To evaluate the effect of adjuvant chemoradiotherapy (CRT) on locoregional control (LRC), disease-free survival (DFS), and overall survival (OS) for patients with extrahepatic biliary tract cancer treated with curative resection...
  17. ncbi Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer
    Guh Jung Seo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    J Surg Oncol 102:94-9. 2010
    ..The aim of this study was to compare the incidence of major intestinal complications in asymptomatic patients who received palliative treatment for unresectable stage IV CRC, according to the type of treatment...
  18. ncbi The effect of belly board location in rectal cancer patients treated with preoperative radiotherapy
    Seok Ho Lee
    Research Institute and Hospital, National Cancer Centre, Goyang, Republic of Korea
    Clin Oncol (R Coll Radiol) 18:441-6. 2006
    ..When considering the use of a belly board in routine clinical practice, we recommend that the clinician take into account the patterns of irradiated small bowel volume according to belly board aperture location...
  19. ncbi A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer
    Sun Young Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, 111 Jungbalsan ro, Ilsandong gu, Goyang si, Gyeonggi Do, 410 769, Republic of Korea
    Invest New Drugs 27:269-74. 2009
    ..3%), diarrhea (two, 10.5%) and fatigue (two, 10.5%). TIROX seemed to be feasible and efficacious for refractory mCRC patients, and could be an alternative for patients with good PS but no further treatment options...
  20. ncbi Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?
    Seog Yun Park
    Department of Pathology, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Histopathology 59:650-9. 2011
    ..To assess the efficacy of the step section for determination of pathological complete response (pCR) in rectal cancer treated with preoperative chemoradiotherapy (CRT)...
  21. ncbi Is the N1c category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy?
    Joon Seon Song
    Department of Pathology, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Cancer 117:3917-24. 2011
    ....
  22. ncbi Secondary neutron doses for several beam configurations for proton therapy
    Dongho Shin
    Proton Therapy Center, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 74:260-5. 2009
    ..To compare possible neutron doses produced in scanning and scattering modes, with the latter assessed using a newly built passive-scattering proton beam line...
  23. ncbi Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer
    Jin Soo Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    J Surg Oncol 104:486-92. 2011
    ..Few studies have focused on distribution of lymph node metastasis. The aim of this study is to evaluate the prognostic significance of the location of involved lymph nodes in patients with advanced mid or low rectal cancer...
  24. ncbi Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01)
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Ann Surg 252:998-1004. 2010
    ....
  25. ncbi Clinical outcomes of palliative self-expanding metallic stents in patients with malignant colorectal obstruction
    Byung Chang Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang si, Gyeonggi Do, Korea
    J Dig Dis 13:258-66. 2012
    ..The aim of this study was to evaluate the clinical outcomes of SEMS to palliate colorectal malignant obstruction...
  26. ncbi Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer
    Sang Min Yoon
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 69:1167-72. 2007
    ..To identify pretreatment clinical parameters that could predict pathologic tumor response to preoperative chemoradiotherapy (CRT) for rectal cancer...
  27. ncbi Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer
    Yun Hyung Ha
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang si, Gyeonggi Do, Korea
    Ann Surg 252:336-40. 2010
    ..To evaluate the relation of preoperative chemoradiotherapy to the number of lymph nodes retrieved in curative intent surgery for rectal cancer...
  28. ncbi Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy
    Woong Sub Koom
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea
    Int J Radiat Oncol Biol Phys 68:1446-54. 2007
    ..To compare the dose-volume histogram (DVH) parameters obtained by three-dimensional gynecologic brachytherapy planning with the rectosigmoid mucosal changes observed by flexible sigmoidoscopy...
  29. ncbi Prognostic impact of peritonealisation in rectal cancer treated with preoperative chemoradiotherapy: extraperitoneal versus intraperitoneal rectal cancer
    Mi Ri Hwang
    Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Radiother Oncol 94:353-8. 2010
    ..The aim of this study is to evaluate the prognostic impact of peritonealisation in rectal patients treated by preoperative CRT...
  30. ncbi The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    J Surg Oncol 102:789-95. 2010
    ....
  31. ncbi Feasibility study of glass dosimeter for in vivo measurement: dosimetric characterization and clinical application in proton beams
    Jeong Eun Rah
    Department of Radiation Oncology, Myongji Hospital, Kwandong University College of Medicine, Goyang, Korea
    Int J Radiat Oncol Biol Phys 84:e251-6. 2012
    ..To evaluate the suitability of the GD-301 glass dosimeter for in vivo dose verification in proton therapy...
  32. ncbi Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?
    Sang Hui Moon
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Cancer 118:4961-8. 2012
    ..Although ypStage has been known as a strong prognosticator of recurrence and survival, the detailed interaction of ypT and ypN classification on a survival rate has never been evaluated...
  33. ncbi Absence of hMLH1 or hMSH2 expression as a stage-dependent prognostic factor in sporadic colorectal cancers
    Ji Won Park
    National Cancer Center, Goyang, Republic of Korea
    Ann Surg Oncol 17:2839-46. 2010
    ..The predictive role of mismatch repair (MMR) status for survival after sporadic colorectal cancer remains a point of controversy. This study was designed to test the prognostic value of MMR status in sporadic colorectal cancers...
  34. ncbi Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery
    Ji Won Park
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Republic of Korea
    Int J Radiat Oncol Biol Phys 74:810-7. 2009
    ..To evaluate the role of serum carcinoembryonic antigen (CEA) as a predictor of response to preoperative chemoradiotherapy (CRT) and prognostic factor for rectal cancer...
  35. ncbi Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment
    Myonggeun Yoon
    Proton Therapy Center, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 71:1091-102. 2008
    ..To quantify proton radiotherapy dose reduction in the prostate target volume because of the three-dimensional movement of the prostate based on an analysis of dose-volume histograms (DVHs)...
  36. ncbi Early intrapulmonary recurrence after pulmonary metastasectomy related to colorectal cancer
    Mi Ri Hwang
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Ann Thorac Surg 90:398-404. 2010
    ..Early intrapulmonary recurrence is a major problem after pulmonary metastasectomy related to colorectal cancer. However, the risk factors for early intrapulmonary recurrence are not clear...
  37. ncbi Resected colorectal liver metastases: does the survival differ according to postoperative chemotherapy regimen?
    Sun Young Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    J Surg Oncol 100:713-8. 2009
    ..We compared clinical outcomes in patients who were treated with different chemotherapeutic regimens after resection of hepatic metastases from colorectal cancer (CRC)...
  38. ncbi Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer
    Seong Dae Lee
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Gyeonggi Do, South Korea
    Int J Colorectal Dis 24:1451-8. 2009
    ..In rectal cancer patients treated with preoperative chemoradiotherapy (CRT) and curative resection, we evaluated the influence of anemia on tumor response to preoperative CRT...
  39. ncbi No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients
    Yeon Joo Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi Do, Republic of Korea
    Clin Chim Acta 413:511-5. 2012
    ..Although serum carcinoembryonic antigen (CEA) levels reflect tumor volume in rectal cancer patients intrapersonally, it is unclear interpersonally. We determined the correlation between pretreatment serum CEA levels and tumor volume...
  40. ncbi Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Int J Radiat Oncol Biol Phys 84:e585-92. 2012
    ..To compare chemotherapy alone with chemoradiation therapy in stage III-IV(M0) gastric cancer treated with R0 gastrectomy and D2 lymph node dissection...
  41. ncbi Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection
    Tae Hyun Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Ann Surg Oncol 15:729-37. 2008
    ....
  42. ncbi Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?
    Duck Woo Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Cancer 106:1694-700. 2006
    ..The current study investigated the correlation between tumor involvement in regional lymph nodes and rectal mural tumor status in patients who underwent preoperative CRT for rectal cancer...
  43. ncbi Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer
    Tae Yoo
    Center for Liver Cancer, Research Institute and Hospital, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 81:e623-30. 2011
    ..Thus, we analyzed the effect of clinical parameters on tumor response, early distant metastasis within 3 months (DM(3m)), and overall survival to identify an indicator for selecting patients who would benefit from CRT...
  44. ncbi Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer
    Seung Gu Yeo
    Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Radiother Oncol 97:307-11. 2010
    ..To investigate the efficacy of curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer...
  45. ncbi A new homogeneity index based on statistical analysis of the dose-volume histogram
    Myonggeun Yoon
    Research Institute and Hospital, National Cancer Center, Goyang, Korea
    J Appl Clin Med Phys 8:9-17. 2007
    ..A guideline for evaluating the dose homogeneity of treatment plans based on the S-index and its relation to equivalent uniform dose is discussed...
  46. ncbi Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer
    Yong Sang Hong
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    BMC Cancer 9:246. 2009
    ....
  47. ncbi SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas
    Woong Sub Koom
    Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea
    Head Neck 30:159-69. 2008
    ..Concurrent chemoradiotherapy is commonly used for locally advanced nasopharyngeal carcinoma (NPC). We retrospectively analyzed the clinical outcomes of simultaneous modulated accelerated radiotherapy (SMART) with concurrent chemotherapy...
  48. ncbi Intensity-modulated radiotherapy with a belly board for rectal cancer
    Joo Young Kim
    Research Institute and Hospital, National Cancer Center, Goyang, South Korea
    Int J Colorectal Dis 22:373-9. 2007
    ..The aim of this study was to determine whether additional use of a belly board reduced the irradiated small bowel volume observed using IMRT alone in rectal cancer patients...
  49. ncbi Optimal matching of 3D film-measured and planned doses for intensity-modulated radiation therapy quality assurance
    Dongho Shin
    Research Institute and Hospital, National Cancer Center, Ilsandong gu, Goyang, Republic of Korea
    Med Dosim 32:316-24. 2007
    ..The results of 3D optimization are discussed in terms of various patient-specific QA data obtained from statistical analyses...
  50. ncbi Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer
    Young Hoon Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea
    Int J Radiat Oncol Biol Phys 62:761-8. 2005
    ..However, the MR volumetric evaluation could not identify any differences between those patients having a complete histologic regression and those with residual disease...
  51. ncbi Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Am J Clin Oncol 29:568-75. 2006
    ..Both primary tumor and PVT responses were found to be prognostic factors for overall survival. The present results suggest 3D-CRT is a practical treatment option in HCC patients for whom TACE is ineffective or unsuitable...
  52. ncbi Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 67:225-31. 2007
    ..To identify the dose-volumetric parameters associated with the risk of radiation-induced hepatic toxicity (RIHT) in hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy...
  53. ncbi Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type
    Dae Kyung Sohn
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    J Clin Pathol 60:912-5. 2007
    ..To evaluate the histopathological risk factors for lymph node metastasis in cases of pedunculated or semipedunculated submucosal invasive colorectal carcinoma (SICC)...
  54. ncbi Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Radiat Oncol 5:97. 2010
    ..To investigate whether whole-liver radiotherapy (RT) is beneficial in end-stage colorectal cancer with massive liver metastases and severe hepatic dysfunction...
  55. ncbi Computerized tomography-based quality assurance tool for proton range compensators
    Myonggeun Yoon
    Proton Therapy Center, National Cancer Center, Ilsandong gu, Goyang, 411 769, Korea
    Med Phys 35:3511-7. 2008
    ..3% to 0.9%. Their results show that depth comparison of proton range compensators based on CT images can provide more systematic data than does the current method, in which a representative group of drill points is measured manually...
  56. ncbi Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01)
    Dae Yong Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea
    Dis Colon Rectum 49:1684-91. 2006
    ..In addition, the clinicians choosing to use concomitant small field boost irradiation should be cautious to minimize the risk of unplanned sphincter ablation...
  57. ncbi Preoperative Short-Course Concurrent Chemoradiation Therapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer: A Phase 2 Multicenter Study (KROG 10-01)
    Seung Gu Yeo
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea Department of Radiation Oncology, Soonchunhyang University College of Medicine, Cheonan, Korea
    Int J Radiat Oncol Biol Phys 86:34-9. 2013
    ..A prospective phase 2 multicenter trial was performed to investigate the efficacy and safety of preoperative short-course concurrent chemoradiation therapy (CRT) followed by delayed surgery for patients with locally advanced rectal cancer...
  58. ncbi Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
    Joo Ho Lee
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Radiat Oncol 6:51. 2011
    ..To assess the clinical outcome of chemoradiotherapy with or without surgery for locally recurrent rectal cancer (LRRC) and to find useful and significant prognostic factors for a clinical situation...
  59. ncbi Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy
    Ji Yeon Baek
    Center for Colorectal Cancer, National Cancer Center, 323 Ilsan ro, Ilsandong gu, Goyang, Gyeonggi, 410 769, Republic of Korea
    J Neurooncol 104:745-53. 2011
    ..Thus, additional chemotherapeutic intervention after BM associated with CRC may be beneficial for selected patients...
  60. ncbi Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography
    Seok-Byung Lim
    Research Institute and Hospital, National Cancer Center, Goyang, and Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea
    World J Gastroenterol 12:6689-92. 2006
    ..CONCLUSION: As MSI is one of the established fecal DNA markers to screen colorectal cancer, we propose to use DHPLC for the MSI analysis in fecal DNA...
  61. ncbi The effect of a contrast agent on proton beam range in radiotherapy planning using computed tomography for patients with locoregionally advanced lung cancer
    Ui Jung Hwang
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
    Int J Radiat Oncol Biol Phys 81:e317-24. 2011
    ..We evaluated the effect of a contrast agent (CA) on proton beam range in a treatment planning system (TPS) for patients with locoregionally advanced lung cancer...
  62. ncbi CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters
    Kyung Hwan Shin
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    Int J Radiat Oncol Biol Phys 64:197-204. 2006
    ..To ascertain the potential benefit of treatment outcome, ICR with image-guided three-dimensional plans will be pursued and correlated with the dose-volume parameters...
  63. ncbi Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer
    Young Kyung Lim
    Proton Therapy Center, National Cancer Center, Goyang, Gyeonggi, Korea
    Int J Radiat Oncol Biol Phys 74:1609-16. 2009
    ....
  64. ncbi Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea
    Int J Radiat Oncol Biol Phys 62:769-75. 2005
    ..The combination of the BBD and DB showed an additive effect and was the most effective method for reducing the irradiated small bowel volume...
  65. ncbi Optimized matching of film dosimetry with calculated doses for IMRT quality assurance
    Dong Hyun Park
    Proton Therapy Center, National Cancer Center, Ilsan gu, Goyang 411 769, Korea
    Phys Med 23:49-57. 2007
    ..Similar results are obtained for IMRS. This method dramatically reduces the difference between measured and calculated dose distributions in all cases investigated...
  66. ncbi Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy
    Tae Hyun Kim
    Research Institute and Hospital, National Cancer Center, Madu 1-dong, Ilsan-gu, Goyang, Gyeonggi 411-769, South Korea
    Int J Radiat Oncol Biol Phys 62:995-1002. 2005
    ..For patients being treated with concurrent chemotherapy, V60 is considered to be a useful parameter predicting the risk of severe AET after conventionally fractionated 3D-CRT for lung cancer...
  67. ncbi Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma
    Hee Jin Chang
    Research Institute and Hospital, National Cancer Center, Gyeonggi 411-764, Korea
    Hum Pathol 36:364-71. 2005
    ..017). This result confirms that apoptosis plays an important role in tumor response to CRT and provides evidence that Bax may serve as a predictable molecular marker for chemoradiosensitivity in rectal carcinoma...
  68. ncbi Geometric shifting of the porta hepatis during posthepatectomy radiotherapy for biliary tract cancer
    Whoon Jong Kil
    Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 66:212-6. 2006
    ..We recommend an additional RT margin or adaptive RT (repeat planning at several intervals during the treatment course) to avoid exclusion of the porta hepatis from the RT target volume after partial hepatectomy for biliary tract cancer...
  69. ncbi [Radiation therapy for rectal cancer]
    Dae Yong Kim
    Center for Colorectal Cancer, National Cancer Center, Goyang, Korea
    Korean J Gastroenterol 47:285-90. 2006
    ..However, diagnostic imaging for accurate stage should be applied. In addition, chemotherapeutic regimen, schedule for radiation therapy, and timing of surgery should be also optimized in order to maximize the effect of preoperative CRT...
  70. ncbi Radiation-induced Necrosis Deteriorating Neurological Symptoms and Mimicking Progression of Brain Metastasis after Stereotactic-guided Radiotherapy
    Young Zoon Kim
    Neuro Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Cancer Res Treat 39:16-21. 2007
    ..Therefore, specific diagnostic tools that can distinguish RIN from progression of metastatic brain tumor need to be developed...
  71. ncbi Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma
    Dae Yong Kim
    Research Institute and Hospital, National Cancer Center, Gyeonggi, Korea
    Cancer 103:2419-26. 2005
    ..A dose-response relation was found to exist between the RT dose and PVT response. These results suggested that RT may be a treatment option for PVT in patients with HCC and that an RT dose > or = 58 Gy(10) should be recommended...